Introduction: There is continued unmet medical need for new medicines across countries especially for cancer, immunological diseases, and orphan diseases. However, there are growing challenges with ...
Let’s dive into the details with these 10 images. Revealed at the Bharat Mobility Global Expo 2025 (aka Auto Expo 2025), this ultra-premium electric MPV is the second addition to MG’s elite ...
The MG Majestor made its grand debut at Auto Expo 2025, as another entrant in the Indian SUV market. We break down the key design elements and expected features of the Majestor in our image gallery.
TVF (The Viral Fever) is one of the most loved content producers, consistently delivering relatable content for audiences. With their highly engaging and captivating shows, they are the only ...
The electric vehicle’s flat-bottom steering boasts the octagonal ‘MG’ logo, behind which sits a 10.25-inch driver’s display. Two 7-inch screens are placed on either side of the larger display.
MG introduced the Majestor three-row SUV at the Bharat Mobility Expo in India. The new SUV is a basically rebadged Maxus/LDV D90. MG describes the Majestor as the “tallest, longest, and widest ...
Although MG hasn’t revealed exact specifications yet, going by the dimensions of the international-spec D90 Max, the Majestor could measure 5,046mm in length, 2,016mm in width and 1,876mm in ...
I am an 84-year-old male in fairly good health for my age. I take 8-10 pills a day, including two over-the-counter ...
JSW MG Motor India has unveiled two new cars at the Bharat Mobility Global Expo 2025. Introducing the MG Cyberster, India’s first all-electric roadster, and the MG M9, the country’s first ...
MG showcased three new offerings, including an electric MPV, a flagship SUV and an SUV with a new powertrain option at the Auto Expo 2025 MG has gone all guns blazing at the Bharat Mobility Global ...
The M9 positions MG in the premium electric MPV segment and will be offered exclusively through the brand's 'Select' dealerships MG to retail the premium M9 MPV via its new ‘Select’ dealerships.
The FDA has approved a third biosimilar for tocilizumab, called Avtozma, the second such biosimilar to be available in both intravenous and subcutaneous formulations, according to a press release.